Finland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Monoklonaaliset
Pohjois-Pohjanmaan hyvinvointialue awarded a contract of undisclosed value to Amgen Aktiebolag, filial i Finland for Professional Services & Consulting in December 2024 — one of 366 awards this buyer has made.
Buying agency
Pohjois-Pohjanmaan hyvinvointialueWinning supplier
Amgen Aktiebolag, filial i FinlandContract description
Finland – General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents – Monoklonaaliset vasta-aineet ajalle 1.1.-31.12.2025 + optiovuosi 2026
Related awards · Pohjois-Pohjanmaan hyvinvointialue
366 awardsThe buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.
- ocds-ted-672047-2025Veho Oy Ab€10.7M13 Oct 2025 Healthcare
- ocds-ted-415080-2026NCC Suomi Oy€10.0M17 Jun 2026 Construction
- ocds-ted-720042-2025Rakennusliike LAPTI Oy€8.7M31 Oct 2025 Construction
Other wins · Amgen Aktiebolag, filial i Finland
3 winsThe supplier's complete win history across every buyer it sells to — not just the handful shown here.
- ocds-ted-144457-2024-5Pohjois-Pohjanmaan hyvinvointialueNot disclosed08 Mar 2024 Healthcare
- ocds-ted-61474-2024-2Pohjois-Pohjanmaan hyvinvointialueNot disclosed30 Jan 2024 Professional Services
Premium · full dataset
See the full award context.
Competing bids, award margins and every related contract for Pohjois-Pohjanmaan hyvinvointialue and Amgen Aktiebolag, filial i Finland — one subscription unlocks everything.
Sign Up Free →Free account · cancel anytime · 14-day money-back